Cas No.: 1926163-30-5
PRODUCT INFORMATION
Description
This tumor-targeted pro-apoptotic peptide, CNGRC-GG-D(KLAKLAK)₂, integrates a tumor-homing CNGRC domain (targeting CD13) and a cytotoxic (KLAKLAK)₂ module. The (KLAKLAK)₂ moiety destabilizes mitochondrial membranes to induce caspase-dependent apoptosis in target cell lines. Its disulfide-bridged architecture enhances accumulation in research models, demonstrating potent in vitro cytotoxic activity.
Molecular Weight
2168.72
Purity
> 95%
Formula
C₉₄H₁₇₄N₃₂O₂₂S₂
Product Type
Targeting Peptide
Sequence
Cys-Asn-Gly-Arg-Cys-Gly-Gly-Lys-Leu-Ala-Lys-Leu-Ala-Lys-Lys-Leu-Ala-Lys-Leu-Ala-Lys-NH₂ (Disulfide bridge:Cys1-Cys5)
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- Breast Cancer Targeting Peptide 18-4 (CAT#: OLY-1025-YS-23)
- CooP Targeting Peptide (CAT#: OLY-1025-YS-12)
- MH42 Targeting Peptide (CAT#: OLY-1025-YS-31)
- Octreotide Targeting Peptide (CAT#: OLY-1025-YS-3)
- M2 Targeting Peptide (CAT#: OLY-1025-YS-40)
- GPC3 Targeting Peptide 1 (CAT#: OLY-1025-YS-37)
- Cyclo(Arg-Ala-Asp-(D-Tyr)-Lys) Targeting Peptide (CAT#: OLY-1025-YS-36)
- CGGK Targeting Peptide (CAT#: OLY-1025-YS-27)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.